Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance - PubMed (original) (raw)
Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance
Niklas Zojer et al. Br J Haematol. 2002 Jun.
Free article
Abstract
In the present study, we aimed to identify distinct structural and numerical chromosomal aberrations in peripheral blood B cells of patients with myeloma and monoclonal gammopathy of undetermined significance (MGUS), which reflect changes thought to occur at different stages of the disease process. Peripheral blood from 12 patients with multiple myeloma and three patients with MGUS was investigated for the occurrence of retinoblastoma-1 gene deletions, p53 gene deletions and numerical aberrations demonstrated previously to be present in the patients' bone marrow CD138+ cells. By combining immunocytochemical staining for light chains and interphase fluorescence in situ hybridization (FISH), aberrant light-chain +ve cells were detected in the circulating CD19+ cell fraction. Each kind of chromosomal change present in the myeloma tumour cells was found to be shared by a small fraction of CD19+ cells (0.1-1.8%; median 0.36%, n = 6). In one MGUS patient, aberrant cells could be identified with a frequency of 0.34% within the CD19-sorted cell fraction. Clonotypic cells were detected with a frequency of 0.01-0.07% of peripheral blood nucleated cells by m-RNA in situ hybridization with patient-specific probes in three investigated patients. These results provide evidence that the circulating clonotypic B cells are closely related to the malignant plasma cells in myeloma and MGUS.
Similar articles
- Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A. Rasillo A, et al. Cancer. 2003 Feb 1;97(3):601-9. doi: 10.1002/cncr.11100. Cancer. 2003. PMID: 12548602 - The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M. Nishida K, et al. Blood. 1997 Jul 15;90(2):526-34. Blood. 1997. PMID: 9226151 - Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
Chiecchio L, Dagrada GP, Ibrahim AH, Dachs Cabanas E, Protheroe RK, Stockley DM, Orchard KH, Cross NC, Harrison CJ, Ross FM; UK Myeloma Forum. Chiecchio L, et al. Haematologica. 2009 Dec;94(12):1708-13. doi: 10.3324/haematol.2009.011064. Haematologica. 2009. PMID: 19996118 Free PMC article. - The presence of circulating clonal CD19+ cells in multiple myeloma.
Rasmussen T. Rasmussen T. Leuk Lymphoma. 2001 Nov-Dec;42(6):1359-66. doi: 10.3109/10428190109097764. Leuk Lymphoma. 2001. PMID: 11911420 Review. - Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Almeida J, Orfao A, Mateo G, Ocqueteau M, García-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A, Mejido M, San Miguel JF. Almeida J, et al. Pathol Biol (Paris). 1999 Feb;47(2):119-27. Pathol Biol (Paris). 1999. PMID: 10192879 Review.
Cited by
- Natural history of multiple myeloma with de novo del(17p).
Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Blood Cancer J. 2019 Mar 7;9(3):32. doi: 10.1038/s41408-019-0191-y. Blood Cancer J. 2019. PMID: 30846679 Free PMC article. - Cancer stem cells of differentiated B-cell malignancies: models and consequences.
Gross E, Quillet-Mary A, Ysebaert L, Laurent G, Fournie JJ. Gross E, et al. Cancers (Basel). 2011 Mar 25;3(2):1566-79. doi: 10.3390/cancers3021566. Cancers (Basel). 2011. PMID: 24212774 Free PMC article. - Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Thiago LS, Perez-Andres M, Balanzategui A, Sarasquete ME, Paiva B, Jara-Acevedo M, Barcena P, Sanchez ML, Almeida J, González M, San Miguel JF, Garcia-Sanz R, Orfao A. Thiago LS, et al. Haematologica. 2014 Jan;99(1):155-62. doi: 10.3324/haematol.2013.092817. Epub 2013 Jul 19. Haematologica. 2014. PMID: 23872308 Free PMC article. - In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.
Debes Marun CS, Belch AR, Pilarski LM. Debes Marun CS, et al. Am J Hematol. 2012 Jun;87(6):579-87. doi: 10.1002/ajh.23194. Epub 2012 Apr 12. Am J Hematol. 2012. PMID: 22495885 Free PMC article. - Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.
Trepel M, Martens V, Doll C, Rahlff J, Gösch B, Loges S, Binder M. Trepel M, et al. PLoS One. 2012;7(2):e31998. doi: 10.1371/journal.pone.0031998. Epub 2012 Feb 22. PLoS One. 2012. PMID: 22384124 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous